0
Editorial |

Waiting Time in Prostate Cancer

Alfred I. Neugut, MD, PhD; Victor R. Grann, MD, MPH
JAMA. 2004;291(22):2757-2758. doi:10.1001/jama.291.22.2757.
Text Size: A A A
Published online

Extract

The study from Johansson and colleagues1 published in this issue of THE JOURNAL illustrates why oncologists often substitute the jargon of survival rates to sidestep using the magic word cure, which is really what's on every patient's mind.1 In this well-conducted investigation, the researchers complete more than 2 decades of follow-up for a cohort of more than 200 Swedish men with early-stage prostate cancer from before the prostate-specific antigen (PSA) era who were treated with watchful waiting. Earlier reports by Johansson et al documented the relatively high rates of recurrence and mortality for those with high-grade tumors and the relatively lower rates among those with low-grade tumors, extending up to about 15 years of follow-up.28 In the current article, the authors extend their follow-up to more than 20 years and find a surprising acceleration in the recurrence and mortality rates of the patients with low-grade tumors.1 The result is that more aggressive disease indeed occurs after 15 years of follow-up for these patients.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 3

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();